Trans-L-Diaminocyclohexane Oxalatoplatinum: Revolutionizing Cancer Therapy
A cornerstone in advanced cancer treatment, offering potent efficacy with reduced side effects.
Get a Quote & SampleProduct Core Value
Trans-L-Diaminocyclohexane Oxalatoplatinum
This platinum-based antineoplastic agent is a critical component in the treatment of advanced colorectal cancer. Its mechanism involves forming DNA cross-links, thereby inhibiting DNA synthesis and ultimately leading to cancer cell death. It is often administered intravenously as part of combination therapies like FOLFOX and CAPOX regimens.
- Leveraging platinum-based chemotherapy for advanced colorectal cancer treatment provides significant clinical benefits.
- Understanding the Oxaliplatin DNA cross-linking mechanism is key to its therapeutic effectiveness.
- The drug exhibits Oxaliplatin side effects, primarily neurotoxicity, which require careful management.
- As part of the WHO Essential Medicines Oxaliplatin list, it signifies its global importance in healthcare.
Key Advantages
Reduced Toxicity Profile
Compared to earlier platinum-based drugs, this agent generally presents with less ototoxicity and nephrotoxicity, enhancing patient tolerance and allowing for more consistent application of chemotherapy drug development history insights.
Established Efficacy in Combinations
Its inclusion in regimens like FOLFOX and CAPOX demonstrates its proven ability to enhance treatment outcomes in treating advanced cancer, a testament to careful pharmaceutical intermediate for oncology research.
Broad Application Spectrum
Beyond colorectal cancer, its utility extends to pancreatic, stomach, and other cancers, showcasing its versatility in cancer therapy.
Key Applications
Colorectal Cancer Treatment
A primary indication, often used in combination with other agents to manage advanced stages of the disease, drawing from extensive chemotherapy drug development history.
Pancreatic Cancer Management
Plays a role in treatment protocols for pancreatic cancers, contributing to the overall efficacy of combined therapeutic approaches.
Oncology Drug Development
Its established profile makes it a crucial benchmark and component in the ongoing research for new and improved platinum-based chemotherapy agents.
Pharmaceutical Intermediates
Serves as a vital pharmaceutical intermediate for oncology, underpinning the production of advanced cancer therapeutics.